# Crawford & Co: overview

CRD-A · NYSE · CIK 25475 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crd-a.md) · [Financials](/companies/crd-a/financials.md) · [Filings](/companies/crd-a/filings.md) · [Insiders](/companies/crd-a/insiders.md)

Latest reported revenue: [$330.0m](/filings/0001193125-26-330643.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-330643).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [343](/filings/0001193125-25-262728.md) | [358 d](/filings/0001193125-26-116011.md) | [323](/filings/0001193125-26-204372.md) | [335](/filings/0001193125-26-330643.md) | [333](/filings/0001193125-25-262728.md) | [320 d](/filings/0001193125-26-116011.md) | [320](/filings/0001193125-26-204372.md) | [330](/filings/0001193125-26-330643.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [2.8%](/filings/0001193125-25-262728.md) | [1.6% d](/filings/0001193125-26-116011.md) | [2.1%](/filings/0001193125-26-204372.md) | [2.3%](/filings/0001193125-26-330643.md) | [3.7%](/filings/0001193125-25-262728.md) | [(2.3%) d](/filings/0001193125-26-116011.md) | [1.5%](/filings/0001193125-26-204372.md) | [4.1%](/filings/0001193125-26-330643.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [17.8 d](/filings/0001193125-25-262728.md) | [37.3 d](/filings/0001193125-26-116011.md) | [(14.9)](/filings/0001193125-26-204372.md) | [33.6 d](/filings/0001193125-26-330643.md) | [29.3 d](/filings/0001193125-25-262728.md) | [46.9 d](/filings/0001193125-26-116011.md) | [1.4](/filings/0001193125-26-204372.md) | [18.6 d](/filings/0001193125-26-330643.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,139](/filings/0000950170-24-024987.md) | [1,231](/filings/0000950170-25-030894.md) | [1,317](/filings/0001193125-26-116011.md) | [1,341](/filings/0001193125-26-116011.md) | [1,311](/filings/0001193125-26-116011.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [2.7%](/filings/0000950170-24-024987.md) | [(1.5%)](/filings/0000950170-25-030894.md) | [2.3%](/filings/0001193125-26-116011.md) | [2.0%](/filings/0001193125-26-116011.md) | [1.5%](/filings/0001193125-26-116011.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [45.1](/filings/0000950170-24-024987.md) | [20.8](/filings/0000950170-25-030894.md) | [98.9](/filings/0001193125-26-116011.md) | [45.4](/filings/0001193125-26-116011.md) | [94.8](/filings/0001193125-26-116011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/crd-a/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.9m | 1,943,110 |  | Added +162,774 |
| [TRUIST FINANCIAL CORP](/funds/92230.md) | 2026-06-30 | $18.3m | 1,623,485 |  | Unchanged |
| [CAPITAL MANAGEMENT CORP /VA](/funds/1074273.md) | 2026-06-30 | $16.7m | 1,480,105 |  | Added +14,070 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $10.5m | 932,153 |  | Added +18,829 |
| [TRUIST FINANCIAL CORP](/funds/92230.md) | 2026-06-30 | $9.8m | 941,853 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.5m | 910,707 |  | Reduced −247 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $7.6m | 672,607 |  | Added +207,783 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $6.0m | 579,910 |  | Reduced −13,900 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $6.0m | 573,449 |  | Added +2,000 |
| [CAPITAL MANAGEMENT CORP /VA](/funds/1074273.md) | 2026-06-30 | $5.7m | 542,176 |  | Added +26,434 |

## Recent filings

[All 1,345 filings](/companies/crd-a/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 16:30 ET | [8-K](/filings/0001104659-26-094089.md) | 8.01 Other events | 0001104659-26-094089 |
| 2026-08-03 | 16:24 ET | [10-Q](/filings/0001193125-26-330643.md) | Quarterly report, period 2026-06-30 | 0001193125-26-330643 |
| 2026-08-03 | 16:19 ET | [8-K](/filings/0001193125-26-330626.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-330626 |
| 2026-05-19 | 15:02 ET | [8-K](/filings/0001104659-26-063769.md) | 5.07 Shareholder vote results | 0001104659-26-063769 |
| 2026-05-04 | 17:26 ET | [10-Q](/filings/0001193125-26-204372.md) | Quarterly report, period 2026-03-31 | 0001193125-26-204372 |
| 2026-05-04 | 17:24 ET | [8-K](/filings/0001193125-26-204368.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-204368 |
| 2026-04-09 | 16:30 ET | [DEF 14A](/filings/0001104659-26-041532.md) | Proxy statement, period 2026-05-14 | 0001104659-26-041532 |
| 2026-03-31 | 16:21 ET | [8-K](/filings/0001193125-26-134655.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-134655 |
| 2026-03-23 | 16:42 ET | [8-K](/filings/0001104659-26-033363.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-033363 |
| 2026-03-19 | 16:18 ET | [10-K/A](/filings/0001193125-26-116011.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-116011 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-085465.md), filed Mar 2, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/a271add0-14a9-4503-9120-60c5a6996937)

## About the filer

- CIK: 25475
- Tickers: CRD-A, CRD-B
- Exchange: NYSE
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: GA
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.